Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas

Yasushi Toh, Takefumi Ohga, Shuhei Itoh, Akira Kabashima, Kazuharu Yamamoto, Eisuke Adachi, Yoshihisa Sakaguchi, Takeshi Okamura, Hideki Hirata

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: A radical esophagectomy with extensive lymph node dissection is the mainstay treatment for submucosal esophageal cancer, though definitive chemoradiotherapy (CRT) has also been applied. However, the treatment outcomes have not yet been extensively investigated. Patients and Methods: Forty-nine patients with submucocal esophageal squamous cell carcinoma, 24 and 25 of whom had been treated by a radical esophagectomy with extensive lymph node dissection (Surgery group) and definitive CRT using 5-Fluorouracil and CDDP with concurrent radiation of 60 Gy (CRT group), respectively, formed the study cohort. Results: In the Surgery group, the overall and cause-specific 5-year survival rates were 75.4% and 90.0%, respectively. No operative or hospital deaths had occurred. In the CRT group, a complete response (CR) had been achieved in 22 (88%) patients. The 3- and 5-year overall survival rates were 79.3% and 36.9%, respectively, while the cause-specific 3- and 5-year survival rates were 75.2% and 55.7%, respectively. No treatment-related deaths had occurred. Conclusion: These data suggest that: (i) a radical esophagectomy with extensive lymph node dissection can be a standard treatment offering excellent survival and (ii) a definitive CRT is a reasonable alternative to surgery, especially for patients with complications.

Original languageEnglish
Pages (from-to)2487-2491
Number of pages5
JournalAnticancer research
Volume26
Issue number3 B
Publication statusPublished - May 1 2006

Fingerprint

Chemoradiotherapy
Epithelial Cells
Esophagectomy
Lymph Node Excision
Survival Rate
Therapeutics
Radiation Dosage
Esophageal Neoplasms
Fluorouracil
Cohort Studies
Survival

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Toh, Y., Ohga, T., Itoh, S., Kabashima, A., Yamamoto, K., Adachi, E., ... Hirata, H. (2006). Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas. Anticancer research, 26(3 B), 2487-2491.

Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas. / Toh, Yasushi; Ohga, Takefumi; Itoh, Shuhei; Kabashima, Akira; Yamamoto, Kazuharu; Adachi, Eisuke; Sakaguchi, Yoshihisa; Okamura, Takeshi; Hirata, Hideki.

In: Anticancer research, Vol. 26, No. 3 B, 01.05.2006, p. 2487-2491.

Research output: Contribution to journalArticle

Toh, Y, Ohga, T, Itoh, S, Kabashima, A, Yamamoto, K, Adachi, E, Sakaguchi, Y, Okamura, T & Hirata, H 2006, 'Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas', Anticancer research, vol. 26, no. 3 B, pp. 2487-2491.
Toh, Yasushi ; Ohga, Takefumi ; Itoh, Shuhei ; Kabashima, Akira ; Yamamoto, Kazuharu ; Adachi, Eisuke ; Sakaguchi, Yoshihisa ; Okamura, Takeshi ; Hirata, Hideki. / Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas. In: Anticancer research. 2006 ; Vol. 26, No. 3 B. pp. 2487-2491.
@article{84a0de13906345a2b66cca031230be0a,
title = "Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas",
abstract = "Background: A radical esophagectomy with extensive lymph node dissection is the mainstay treatment for submucosal esophageal cancer, though definitive chemoradiotherapy (CRT) has also been applied. However, the treatment outcomes have not yet been extensively investigated. Patients and Methods: Forty-nine patients with submucocal esophageal squamous cell carcinoma, 24 and 25 of whom had been treated by a radical esophagectomy with extensive lymph node dissection (Surgery group) and definitive CRT using 5-Fluorouracil and CDDP with concurrent radiation of 60 Gy (CRT group), respectively, formed the study cohort. Results: In the Surgery group, the overall and cause-specific 5-year survival rates were 75.4{\%} and 90.0{\%}, respectively. No operative or hospital deaths had occurred. In the CRT group, a complete response (CR) had been achieved in 22 (88{\%}) patients. The 3- and 5-year overall survival rates were 79.3{\%} and 36.9{\%}, respectively, while the cause-specific 3- and 5-year survival rates were 75.2{\%} and 55.7{\%}, respectively. No treatment-related deaths had occurred. Conclusion: These data suggest that: (i) a radical esophagectomy with extensive lymph node dissection can be a standard treatment offering excellent survival and (ii) a definitive CRT is a reasonable alternative to surgery, especially for patients with complications.",
author = "Yasushi Toh and Takefumi Ohga and Shuhei Itoh and Akira Kabashima and Kazuharu Yamamoto and Eisuke Adachi and Yoshihisa Sakaguchi and Takeshi Okamura and Hideki Hirata",
year = "2006",
month = "5",
day = "1",
language = "English",
volume = "26",
pages = "2487--2491",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3 B",

}

TY - JOUR

T1 - Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas

AU - Toh, Yasushi

AU - Ohga, Takefumi

AU - Itoh, Shuhei

AU - Kabashima, Akira

AU - Yamamoto, Kazuharu

AU - Adachi, Eisuke

AU - Sakaguchi, Yoshihisa

AU - Okamura, Takeshi

AU - Hirata, Hideki

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Background: A radical esophagectomy with extensive lymph node dissection is the mainstay treatment for submucosal esophageal cancer, though definitive chemoradiotherapy (CRT) has also been applied. However, the treatment outcomes have not yet been extensively investigated. Patients and Methods: Forty-nine patients with submucocal esophageal squamous cell carcinoma, 24 and 25 of whom had been treated by a radical esophagectomy with extensive lymph node dissection (Surgery group) and definitive CRT using 5-Fluorouracil and CDDP with concurrent radiation of 60 Gy (CRT group), respectively, formed the study cohort. Results: In the Surgery group, the overall and cause-specific 5-year survival rates were 75.4% and 90.0%, respectively. No operative or hospital deaths had occurred. In the CRT group, a complete response (CR) had been achieved in 22 (88%) patients. The 3- and 5-year overall survival rates were 79.3% and 36.9%, respectively, while the cause-specific 3- and 5-year survival rates were 75.2% and 55.7%, respectively. No treatment-related deaths had occurred. Conclusion: These data suggest that: (i) a radical esophagectomy with extensive lymph node dissection can be a standard treatment offering excellent survival and (ii) a definitive CRT is a reasonable alternative to surgery, especially for patients with complications.

AB - Background: A radical esophagectomy with extensive lymph node dissection is the mainstay treatment for submucosal esophageal cancer, though definitive chemoradiotherapy (CRT) has also been applied. However, the treatment outcomes have not yet been extensively investigated. Patients and Methods: Forty-nine patients with submucocal esophageal squamous cell carcinoma, 24 and 25 of whom had been treated by a radical esophagectomy with extensive lymph node dissection (Surgery group) and definitive CRT using 5-Fluorouracil and CDDP with concurrent radiation of 60 Gy (CRT group), respectively, formed the study cohort. Results: In the Surgery group, the overall and cause-specific 5-year survival rates were 75.4% and 90.0%, respectively. No operative or hospital deaths had occurred. In the CRT group, a complete response (CR) had been achieved in 22 (88%) patients. The 3- and 5-year overall survival rates were 79.3% and 36.9%, respectively, while the cause-specific 3- and 5-year survival rates were 75.2% and 55.7%, respectively. No treatment-related deaths had occurred. Conclusion: These data suggest that: (i) a radical esophagectomy with extensive lymph node dissection can be a standard treatment offering excellent survival and (ii) a definitive CRT is a reasonable alternative to surgery, especially for patients with complications.

UR - http://www.scopus.com/inward/record.url?scp=33745529261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745529261&partnerID=8YFLogxK

M3 - Article

C2 - 16821637

AN - SCOPUS:33745529261

VL - 26

SP - 2487

EP - 2491

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3 B

ER -